$3.4 million grant awarded to identify therapeutic treatments for acute respiratory distress syndrome
A four-year, $3.4 million grant to investigate molecular mechanisms and therapeutic treatments for acute respiratory distress syndrome (ARDS) has been awarded to UTHealth Houston researchers